Jacqueline Howard DDS+FollowAstraZeneca’s Cancer Drug Scores Big!AstraZeneca just dropped some major news—its cancer drug Imfinzi, when paired with standard therapy, helped high-risk bladder cancer patients stay cancer-free longer! No new safety issues popped up, and patients could stick with their treatments. Imfinzi’s already a big deal for other cancers, but this new data could mean even more approvals. No wonder AZN stock is getting a little love today! Anyone else watching this stock now? #AstraZeneca #Imfinzi #CancerResearch #Biotech #StockMarket #Health252Share